Picture of Craneware logo

CRW Craneware Share Price

0.000.00%
gb flag iconLast trade - 00:00
TechnologyAdventurousMid CapHigh Flyer

Momentum

Relative Strength (%)
1m-5.51%
3m+15.2%
6m+35.35%
1yr+86.98%
Volume Change (%)
10d/3m-36.61%
Price vs... (%)
52w High-5.29%
50d MA-0.45%
200d MA+24.25%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)27.59
PEG Ratio (f)1.26
EPS Growth (f)27.9%
Dividend Yield (f)1.4%
Valuation (ttm)IndustryMarket
Price to Book Value2.92
Price to Tang. Bookn/a
Price to Free Cashflow9.55
Price to Sales5.24
EV to EBITDA18.2

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.56%
Return on Equity2.86%
Operating Margin10.62%

Financial Summary

Year End 30th JunUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m71.471.4975.58165.54174.02184.55198.721.01%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-2.11+5.8+17.37-56.34-27.6+291.93+9.89n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202430th Jun 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Craneware EPS forecast chart

Profile Summary

Craneware plc is a United Kingdom company that is engaged in the development, licensing, and ongoing support of computer software for the United States healthcare industry. Its value cycle insights are delivered through its Trisus platform for revenue integrity and 340B management, as well as margin and operational intelligence. Its applications and team of experts contextualize operational, financial, and clinical data, providing insights that clearly demonstrate realistic revenue integrity and 340B compliance opportunities for its customers. Its solutions include Trisus Pricing Transparency, Trisus Pricing Analyzer, Trisus Chargemaster, Insight Medical Necessity, Trisus Claims Informatics, Trisus Supply, Appeals Services, Trisus Healthcare Intelligence, Trisus Supplies Assistant, Trisus Medication Analytic Solutions, Sentinel, Sentrex, Sentrex 330, Referral Verification System (Sentrex), Referral Verification System (Senturion), Sentry Core, Senturion Professional Service and others.

Directors

Last Annual
June 30th, 2023
Last Interim
December 31st, 2023
Incorporated
May 19th, 1999
Public Since
September 13th, 2007
No. of Employees
734
Sector
Software & IT Services
Industry
Technology
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
35,333,766

CRW Share Price Performance

Upcoming Events for CRW

Full Year 2024 Craneware PLC Earnings Release

Similar to CRW

Picture of 1Spatial logo

1Spatial

gb flag iconLondon Stock Exchange

Picture of 4Global logo

4Global

gb flag iconLondon Stock Exchange

Picture of Access Intelligence logo

Access Intelligence

gb flag iconLondon Stock Exchange

Picture of accesso Technology logo

accesso Technology

gb flag iconLondon Stock Exchange

Picture of Activeops logo

Activeops

gb flag iconLondon Stock Exchange

FAQ